No Data
No Data
Guangxi Liuyao Group (603368.SH): is actively exploring the development of international trade in traditional Chinese medicine.
Geronghui November 1st | guangxi liuyao group (603368.SH) stated on the interactive platform that the company is leveraging guangxi's geographical advantage facing ASEAN, actively exploring the international trade of traditional chinese medicine.
Guangxi Liuyao Group Co., Ltd. Report for the Third Quarter of 2024
Guangxi Liuyao Group (603368.SH) released its performance for the first three quarters, with a net income of 0.716 billion yuan, a year-on-year growth of 6.13%.
Guangxi Liuyao Group (603368.SH) released its third quarter report for 2024, achieving revenue of 15...
Guangxi Liuyao Group (603368.SH): The net income for the first three quarters was 0.716 billion yuan, a year-on-year increase of 6.13%.
On October 29, Gelonhui announced that guangxi liuyao group (603368.SH) released its third quarter report, with a revenue of 15.99 billion yuan in the first three quarters, a year-on-year increase of 2.41%, a net income of 0.716 billion yuan, a year-on-year increase of 6.13%, a non-net income of 0.7 billion yuan, a year-on-year increase of 5.20%, and a basic earnings per share of 1.87 yuan.
Earnings Working Against Guangxi LiuYao Group Co., Ltd's (SHSE:603368) Share Price
Guangxi Liuyao Group (603368.SH): 36.8421 million shares of restricted shares will be lifted on October 24th.
Guangxi Liuyao Group (603368.SH) announced that the total number of stocks listed this time is 36.8421 million shares. The stock listing date is October 24, 2024.
No Data
No Data